Trial site
Florida Cancer Specialists
- 23running trials
- 15closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Lung cancer10 trials
- Metastatic breast cancer5 trials
- Triple-negative breast cancer5 trials
- Colorectal cancer4 trials
- Prostate cancer4 trials
- Chronic myeloid leukaemia3 trials
- Gastric and oesophageal cancer3 trials
- Head and neck cancer3 trials
- Bladder cancer2 trials
- Chronic lymphocytic leukaemia2 trials
- Endometrial cancer2 trials
- Kidney cancer2 trials
- and 8 more
- Phase
- Phase 317 trials
- Phase 213 trials
- Phase 1/25 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting14 trials
- Completed13 trials
- Recruiting9 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals8 trials
- Pfizer8 trials
- Gilead Sciences3 trials
- Hoffmann-La Roche3 trials
- Eisai Inc.2 trials
- and 12 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Active, not recruiting
Active, not recruiting
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Endometrial cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Terminated
Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
Completed
Completed
Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer
Completed
Completed
Completed
Completed
Completed
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Completed
Completed
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 14 Nov 2026